Campaign details
Brand: OtrivinLead Agency: Mindshare IndiaRegion: APAC
Strategy
Objective
In India, almost 1 in 3 people suffer from a nasal congestion however only 1 in 10 treat it with a specialized treatment like nasal sprays. Research indicates that indifference/inertia are the biggest barrier to trial. The problem of nasal congestion is simply not viewed as something big enough which requires specialized treatment different from Cold and Flu. Hence more often than not, people use Cold and Flu medicines to relieve nasal congestion symptoms
As the category leader, Otrivin's objective was to drive usage of...